TwinBeech Capital’s Intersect ENT, Inc XENT Stock Holding History

TwinBeech Capital’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-20,410	Closed	-$276K	–	619
2020 Q2	$276K	Buy	+20,410	New	+$237K	0.06%	303

Other funds holding XENT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

TwinBeech Capital's XENT Position: Q3 2020 in Review

TwinBeech Capital sold out of Intersect ENT, Inc (XENT) in Q3 2020, closing a stake of 20,410 shares — an estimated $276K sold.

TwinBeech Capital first reported a position in XENT in Q2 2020 and held it in 1 quarter. The position peaked at $276K in Q2 2020. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2020.

TwinBeech Capital reported no remaining Intersect ENT, Inc position as of Q3 2020 after selling out during the quarter.
TwinBeech Capital sold 20,410 Intersect ENT, Inc shares in Q3 2020, an estimated $276K.
TwinBeech Capital first reported a position in Intersect ENT, Inc in Q2 2020 and held it in 1 quarter.
TwinBeech Capital's Intersect ENT, Inc position peaked at $276K in Q2 2020.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2020.

Based on TwinBeech Capital's 13F filing for Q3 2020, filed 16 Nov 2020.